Goodbyes: Look who's leaving now

As industry undergoes sweeping changes, departures continue with a number of high-profile exits.

AstraZeneca's long time Oncology Buiness Unit Director Heather Cahill is finishing up her time at the company this week.

"It’s hard to capture what 2,300-plus days leading the ANZ Oncology Business Unit have meant to me, but looking back, I’m immensely proud of what we achieved together," she said on LinkedIn.

To see the whole article please log in.

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

Retype password

Not a member? Sign up here